Collegium Pharmaceutical, Inc (COLL) stock
COLLNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 11/3044% below fair value
$24.95+0.14 (+0.56%)
Close on Nov 12, 2026Market cap $812.26MP/E 24.9Yield –
Collegium Pharmaceutical price to book ratio
The price-to-book ratio is market cap divided by shareholders' equity.
Collegium Pharmaceutical's price to book ratio was 2.6× on Nov 11, 2026, against 5.4× a year earlier. Over the last 5 years it ranged from 2.3× to 6.3×, with a median of 4.1×.
Price to Book Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 2.6× | −2.7 |
| 2025 | Dec 31, 2025 | 5.3× | +1.4 |
| 2024 | Dec 31, 2024 | 3.9× | −1.7 |
| 2023 | Dec 29, 2023 | 5.7× | +1.7 |
| 2022 | Dec 30, 2022 | 4.0× | +1.4 |
| 2021 | Dec 31, 2021 | 2.6× | −1.4 |
| 2020 | Dec 31, 2020 | 4.0× | −4.2 |
| 2019 | Dec 31, 2019 | 8.2× | +0.1 |
| 2018 | Dec 31, 2018 | 8.1× | +2.2 |
| 2017 | Dec 29, 2017 | 5.9× | +1.0 |
| 2016 | Dec 30, 2016 | 4.9× | −1.1 |
| 2015 | Dec 31, 2015 | 6.1× | – |
See a number that looks wrong?